OHSU Knight Cancer Institute   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Portland Oregon United States (1887)

Organization Overview

First Clinical Trial
2017
NCT03270059
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

OHSU Knight Cancer Institute